Real-world evaluation of the impact of two anti-SARS-CoV-2 monoclonal antibody regimens on COVID-19 hospitalizations in older adults.
Saved in:
| Title: | Real-world evaluation of the impact of two anti-SARS-CoV-2 monoclonal antibody regimens on COVID-19 hospitalizations in older adults. |
|---|---|
| Authors: | Sobolewski KA; Pharmacy Department, Saint Barnabas Medical Center, Livingston, New Jersey, USA., Smoke SM; Pharmacy Department, Saint Barnabas Medical Center, Livingston, New Jersey, USA., Brophy A; Pharmacy Department, Saint Barnabas Medical Center, Livingston, New Jersey, USA., Vassallo AV; Department of Pharmacy, Community Medical Center, Toms River, New Jersey, USA., Chen B; Pharmacy Department, Clara Maass Medical Center, Belleville, New Jersey, USA., Hilden P; Biostatistics Department, Saint Barnabas Medical Center, Livingston, New Jersey, USA., Patterson R; Department of Pharmacy, Community Medical Center, Toms River, New Jersey, USA., Pittiglio M; Department of Pharmacy, Community Medical Center, Toms River, New Jersey, USA., Raja K; Pharmacy Department, Clara Maass Medical Center, Belleville, New Jersey, USA., Handler E; Emergency Department, Saint Barnabas Medical Center, Livingston, New Jersey, USA., Freer C; Emergency and Hospitalist Medicine Service Line, RWJBarnabas Health, West Orange, New Jersey, USA. |
| Source: | Journal of medical virology [J Med Virol] 2022 Jun; Vol. 94 (6), pp. 2493-2499. Date of Electronic Publication: 2022 Mar 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
